Neurological Relevance Preclinical evidence suggests broader neuroprotective potential: In traumatic brain injury models, SS-31 reduced mitochondrial swelling, neuronal loss, and neuroinflammation Aged mice treated with SS-31 showed significantly improved exercise tolerance, muscle strength, and mitochondrial efficiency Studies demonstrate protection against ischemic injury and enhanced cardiac output Phase 3 trials are ongoing for dry age-related macular degeneration and primary mitochondrial myopathy (Stealth BioTherapeutics pipeline) Implications for Brain Aging Mitochondrial dysfunction is a hallmark of brain aging and neurodegeneration
Contact us to explore personalised solutions tailored to your needs.
Herstel & Genezing Peptiden Cartalax (20mg) is een hoogwaardige research peptide die onderzoekers bestuderen binnen kraakbeen-, bindweefsel- en regeneratieonderzoek
The College of Physicians and Surgeons of British Columbia said (new window) it doesn't have specific guidance on prescribing oral BPC-157, but expects licensees to exercise professional judgment to ensure they are providing safe and appropriate patient care
Weeks Tirzepatide dose Notes 14 2.5 mg Initiation only (not for glucose/weight effect) 58 5 mg First maintenance option 912 7.5 mg Increase as tolerated 1316 10 mg Maintenance option 1720 12.5 mg Increase as tolerated 21+ 15 mg (max) Maximum maintenance dose These steps follow the Mounjaro FDA label and Zepbound FDA label
